400 related articles for article (PubMed ID: 16403912)
21. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
[TBL] [Abstract][Full Text] [Related]
22. The prevalence and function of CD4
Cha Z; Gu H; Zang Y; Wang Z; Li J; Huang W; Qin A; Zhu L; Tu X; Cheng N; Song H; Qian B
Int Immunopharmacol; 2018 Aug; 61():132-139. PubMed ID: 29870918
[TBL] [Abstract][Full Text] [Related]
23. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
24. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
25. Infiltration of a mesothelioma by IFN-gamma-producing cells and tumor rejection after depletion of regulatory T cells.
Rudge G; Barrett SP; Scott B; van Driel IR
J Immunol; 2007 Apr; 178(7):4089-96. PubMed ID: 17371963
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
27. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
[TBL] [Abstract][Full Text] [Related]
28. Identification of tonsillar CD4
Sumitomo S; Nakachi S; Okamura T; Tsuchida Y; Kato R; Shoda H; Furukawa A; Kitahara N; Kondo K; Yamasoba T; Yamamoto K; Fujio K
J Autoimmun; 2017 Jan; 76():75-84. PubMed ID: 27653378
[TBL] [Abstract][Full Text] [Related]
29. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
[TBL] [Abstract][Full Text] [Related]
30. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
[TBL] [Abstract][Full Text] [Related]
31. Restored immune response to an MHC-II-Restricted antigen in tumor-bearing hosts after elimination of regulatory T cells.
Nicholl M; Lodge A; Brown I; Sugg SL; Shilyansky J
J Pediatr Surg; 2004 Jun; 39(6):941-6; discussion 941-6. PubMed ID: 15185230
[TBL] [Abstract][Full Text] [Related]
32. Human Endothelial Cells Modulate CD4
Lim WC; Olding M; Healy E; Millar TM
Front Immunol; 2018; 9():565. PubMed ID: 29628925
[TBL] [Abstract][Full Text] [Related]
33. Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors.
Jacobs JF; Idema AJ; Bol KF; Nierkens S; Grauer OM; Wesseling P; Grotenhuis JA; Hoogerbrugge PM; de Vries IJ; Adema GJ
Neuro Oncol; 2009 Aug; 11(4):394-402. PubMed ID: 19028999
[TBL] [Abstract][Full Text] [Related]
34. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
[TBL] [Abstract][Full Text] [Related]
35. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
[TBL] [Abstract][Full Text] [Related]
36. Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma.
Karim R; Jordanova ES; Piersma SJ; Kenter GG; Chen L; Boer JM; Melief CJ; van der Burg SH
Clin Cancer Res; 2009 Oct; 15(20):6341-7. PubMed ID: 19825956
[TBL] [Abstract][Full Text] [Related]
37. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
38. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells.
Vieira PL; Christensen JR; Minaee S; O'Neill EJ; Barrat FJ; Boonstra A; Barthlott T; Stockinger B; Wraith DC; O'Garra A
J Immunol; 2004 May; 172(10):5986-93. PubMed ID: 15128781
[TBL] [Abstract][Full Text] [Related]
39. IL-4 modulation of CD4+CD25+ T regulatory cell-mediated suppression.
Pace L; Pioli C; Doria G
J Immunol; 2005 Jun; 174(12):7645-53. PubMed ID: 15944265
[TBL] [Abstract][Full Text] [Related]
40. Human regulatory T cells suppress proliferation of B lymphoma cells.
Grygorowicz MA; Biernacka M; Bujko M; Nowak E; Rymkiewicz G; Paszkiewicz-Kozik E; Borycka IS; Bystydzienski Z; Walewski J; Markowicz S
Leuk Lymphoma; 2016 Aug; 57(8):1903-20. PubMed ID: 26758248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]